Family Medicine Doctors in Madisonville, TX Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Mary Helen Morrow, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 604 S Madison St, Madisonville, TX 77864 Phone: 936-348-2284 Fax: 936-348-2294 |
Dr. Imelda V Chan-villanueva, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 W Cross St, Madisonville, TX 77864 Phone: 936-348-3418 |
 Mr. Grover Cleveland Hubley Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 813 South State Street Suite 100, Madisonville, TX 77864 Phone: 936-348-3515 Fax: 936-348-3163 |
News Archive
Stem Cell Therapy International and Histostem sign distribution agreement
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Study explores link between primary healthcare provider and patient activation
People with a chronic condition such as diabetes or arthritis may find themselves taking on a more active role in maintaining or improving their own health if there is an ongoing relationship with a primary healthcare provider, according to University of British Columbia research.
Genetic mutations help predict risk of prostate cancer in younger men: Researchers
Prostate cancer has become more common in younger men, and it's often more aggressive in these men. A new study from researchers at the University of Michigan Comprehensive Cancer Center has found that a series of genetic mutations could help detect this early onset prostate cancer.
Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 5 days ago